-
US says to begin blockade of Iranian ports
-
Germany to cut fuel taxes amid Iran war energy shock
-
Pope Leo kicks off African tour under shadow of Trump's ire
-
Singer Luisa Sonza shares 'unique experience' of Coachella debut
-
Australia names Coyle first woman to lead army
-
Rashford with point to prove as Barca target Atletico comeback
-
Iran executed at least 1,639 people in 2025, most since 1989: NGOs
-
Nuggets roll into NBA playoffs, Raptors clinch berth
-
Flagg's sensational rookie season ends with injury
-
Trump says 'not a big fan' of Pope Leo after his anti-war message
-
Spain's Sanchez calls China trade imbalance with EU 'unsustainable'
-
Oil surges, stocks fall as Trump says to blockade Strait of Hormuz
-
Rivers departing as Bucks coach after disappointing season
-
Raptors top Nets, grab No. 5 seed on last day of NBA regular season
-
Greece's ancient sites get climate-change checkup
-
Lost film of French cinema pioneer retrieved from US attic
-
Rory-peat at Masters has McIlroy hungry for more majors
-
Liverpool seek 'special' Anfield night to salvage troubled season
-
Pope Leo XIV heads to Algeria, first stop of African tour
-
Europe reacts to Hungarian leader Orban's electoral defeat
-
Rose frustrated by latest Masters near-miss
-
Scheffler left ruing slow start after Masters record bid falls short
-
Runoff looms as Fujimori leads troubled Peru vote
-
Spain's Sanchez seeks closer China ties amid strains with US
-
Apex Auto Solutions Inc. Unveils Unified Financial Support System Allowing Customers to Manage Multiple Services Through a Single Text
-
Genflow Biosciences PLC Announces International Patent Publication
-
Empire Metals Limited Announces Issue of Shares & Extension of Options
-
Alpha Launches Japan Fund with former Amova Team
-
Karol G to dance her 'Tropicoqueta' at Coachella
-
McIlroy wins second Masters in a row for sixth major title
-
Orban loses Hungary vote to pro-Europe newcomer after 16 yrs in power
-
Lebanon PM says working to get Israeli troop withdrawal
-
Easter truce between Ukraine and Russia ends
-
Villarreal add to Athletic misery, Oviedo survival hopes boosted
-
Peter Magyar: former govt insider promising system change
-
Inter close in on Serie A title after comeback triumph at Como
-
Exit stage right: Hungary's Orban 16-year rule draws to an end
-
Rose fights for Masters win with McIlroy, Young in hunt
-
Orban concedes 'painful' defeat to conservative Magyar in Hungary polls
-
Garcia warned after Masters meltdown
-
Delays mar vote as crisis-hit Peru picks ninth president in decade
-
Irish government announces tax cuts after fuel cost protests
-
Salt and Kohli in the runs as Bengaluru beat Mumbai in IPL
-
Rosenior admits Chelsea in 'difficult place'
-
Man City must respect Arsenal in title showdown: Guardiola
-
McIlroy begins Masters final round as repeat drama looms
-
Sinner sinks Alcaraz to win Monte Carlo Masters, returns to No.1
-
Stuttgart hammer Hamburg to go third in Bundesliga
-
De Zerbi suffers debut defeat as Spurs crisis deepens, City rampant
-
Delays mar voting as crisis-hit Peru picks ninth president in decade
Bausch Health to Announce Third Quarter 2025 Results on October 29
LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, October 29, 2025 |
Time: | 5:00 p.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
###
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll-free) | (908) 541-3785 |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
W.Nelson--AT